These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9708521)
1. In vivo comparison of PET and SPECT radiopharmaceuticals in detecting breast cancer. Amano S; Inoue T; Tomiyoshi K; Ando T; Endo K J Nucl Med; 1998 Aug; 39(8):1424-7. PubMed ID: 9708521 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine. Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503 [TBL] [Abstract][Full Text] [Related]
3. Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose. Choi JY; Kim SE; Shin HJ; Kim BT; Kim JH J Neurooncol; 2000; 46(1):63-70. PubMed ID: 10896206 [TBL] [Abstract][Full Text] [Related]
4. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent. Inoue T; Tomiyoshi K; Higuichi T; Ahmed K; Sarwar M; Aoyagi K; Amano S; Alyafei S; Zhang H; Endo K J Nucl Med; 1998 Apr; 39(4):663-7. PubMed ID: 9544678 [TBL] [Abstract][Full Text] [Related]
5. 18F alpha-methyl tyrosine PET studies in patients with brain tumors. Inoue T; Shibasaki T; Oriuchi N; Aoyagi K; Tomiyoshi K; Amano S; Mikuni M; Ida I; Aoki J; Endo K J Nucl Med; 1999 Mar; 40(3):399-405. PubMed ID: 10086702 [TBL] [Abstract][Full Text] [Related]
6. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer. Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205 [TBL] [Abstract][Full Text] [Related]
8. PET Imaging of Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer imaging with PET and SPECT agents: an in vivo comparison. Palmedo H; Hensel J; Reinhardt M; Von Mallek D; Matthies A; Biersack HJ Nucl Med Biol; 2002 Nov; 29(8):809-15. PubMed ID: 12453590 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester. Zheng QH; Fei X; DeGrado TR; Wang JQ; Stone KL; Martinez TD; Gay DJ; Baity WL; Mock BH; Glick-Wilson BE; Sullivan ML; Miller KD; Sledge GW; Hutchins GD Nucl Med Biol; 2003 Oct; 30(7):753-60. PubMed ID: 14499334 [TBL] [Abstract][Full Text] [Related]
13. [11C]Choline as a potential PET marker for imaging of breast cancer athymic mice. Zheng QH; Stone KL; Mock BH; Miller KD; Fei X; Liu X; Wang JQ; Glick-Wilson BE; Sledge GW; Hutchins GD Nucl Med Biol; 2002 Nov; 29(8):803-7. PubMed ID: 12453589 [TBL] [Abstract][Full Text] [Related]
14. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. Reinhardt MJ; Kubota K; Yamada S; Iwata R; Yaegashi H J Nucl Med; 1997 Feb; 38(2):280-7. PubMed ID: 9025756 [TBL] [Abstract][Full Text] [Related]
15. [Frontal atypical teratoid/rhabdoid tumor evaluated by single-photon emission computerized tomography and positron emission tomography]. Sasajima T; Oda M; Kinouchi H; Hatazawa J; Mizoi K No Shinkei Geka; 2002 Jun; 30(6):639-45. PubMed ID: 12094691 [TBL] [Abstract][Full Text] [Related]
16. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study. Kaira K; Oriuchi N; Otani Y; Shimizu K; Tanaka S; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Dobashi K; Kanai Y; Endou H; Nakajima T; Endo K; Mori M Clin Cancer Res; 2007 Nov; 13(21):6369-78. PubMed ID: 17975149 [TBL] [Abstract][Full Text] [Related]
17. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574 [TBL] [Abstract][Full Text] [Related]
18. [Experimental study of bio-distribution and tumor imaging of 131I in nude mice bearing human breast cancer]. Fan W; Wang GH; Yang MT; Zhang WG; Dai JJ; Yang XC Ai Zheng; 2004 Jul; 23(7):808-11. PubMed ID: 15248917 [TBL] [Abstract][Full Text] [Related]
19. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors. Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of D-isomers of O-18F-fluoromethyl, O-18F-fluoroethyl and O-18F-fluoropropyl tyrosine as tumour imaging agents in mice. Tsukada H; Sato K; Fukumoto D; Kakiuchi T Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1017-24. PubMed ID: 16699766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]